In recent years, social media platforms like TikTok and Reddit have become hubs for people to share deeply personal—and often puzzling—physical and emotional experiences. One such phenomenon gaining attention is  “Sad Nipple Syndrome”  (SNS), a term describing intense negative emotions triggered by nipple stimulation. From sudden sadness to overwhelming guilt, this mysterious condition has left many questioning:  Why does a simple touch evoke such profound feelings?  Let’s unpack what we know so far. What Is Sad Nipple Syndrome? Sad Nipple Syndrome  refers to a range of emotional responses—such as anxiety, despair, shame, loneliness, or even anger—that arise when the nipples are touched. The triggers vary widely: Physical contact : Partner’s touch, breastfeeding, or even friction from clothing. Non-contact stimuli : Temperature changes, wind, or psychological associations. For some, the emotions are fleeting; for others, they linger like a heavy fog. Software en...

Drug discovery is a complex journey that begins with understanding the molecular machinery driving diseases. At the heart of this process lies the identification of ​ classic drug targets —biological molecules that can be modulated by therapeutics to treat or cure illnesses. In this blog, we explore the fundamental principles of drug discovery, focusing on enzymes, G protein-coupled receptors (GPCRs), and transporters, while unraveling the structural and functional intricacies of proteins that make them ideal targets. ​ 1. The Foundation: Druggable Genes and Disease-Causing Targets The completion of the human and pathogen genomes has revolutionized drug discovery, offering a treasure trove of potential targets. However, not all genes are created equal in the context of drug development. A successful drug target must fulfill two criteria: ​ Druggability : The gene product (e.g., protein) must be structurally and functionally amenable to modulation by small molecules or biologics. ​ Dise...

Hubei Teyer Pharmaceutical Co., Ltd. was established in 2002, and is located in Tianmen, a historic city in Hubei Province, the former residence of Chinese "Tea Saint" Lu Yu. Our company is committed to the production and distribution of Ganciclovir and other APIs advanced intermediates for about 20 years. Teyer Pharmaceutical has developed a new synthesis process for Ganciclovir. , and we developed the groundbreaking research of synthesis process on Valganciclovir hydrochloride and obtained the invention patent certificate in 2017. We are the first domestic manufacturer that successfully develop and produce the Monoacetylganciclovir, and our product lines also including the production of Diacetyl ganciclovir, Benzyl ganciclovir, CBZ-valganciclovir. Hubei Teyer Pharmaceutical Co., Ltd is a high-tech enterprise in Hubei Province. Our factory covers an area of 16,000 square meters. We own two GMP raw material synthesis workshops and a capsule tablet workshop, every workshop is ...